The “Apple Watch Series 7” may include the rumored glucose control feature, according to a report on Samsung’s rival portable device, despite the difficulty of measuring blood sugar without drawing blood.
Rumors have been circulating for a few years about an Apple Watch feature for glucose control, which allows users to check blood sugar levels from the portable device. According to a report, this feature could appear in the next generation of Apple Watch.
In a report on the Samsung Galaxy Watch that can gain a non-invasive blood glucose control function, ETNews states that a feature similar to “Apple Watch 7.” will appear. Reference is made to the existing notification about the feature, as well as to Apple’s patent applications, before the feature is marketed which is subject to “reliability and stability” testing.
Apple has obtained several patents related to controlling blood sugar without drawing blood, including one from 2019 that analyzes body odor in case there are changes. Another used an optical absorption spectroscopy system to analyze materials in the blood.
Reports dating back to 2017 also state that CEO Tim Cook has been involved in non-intrusive glucose control testing, and Cook also admits to wearing a continuous glucose monitor for a few weeks.
This feature would change the lives of type 1 diabetics who need to have their blood sugar levels monitored using a constant glucose monitor (CGM) or finger punctures throughout the day. This would probably take many years to achieve the degree of accuracy that diabetics need before dosing with insulin.
A more likely step for Apple is to try to curb the rising number of type 2 diabetics. Apple Watch could monitor a user’s blood glucose level and alert them if they are reading above the norm and that they can be prediabetic. The idea is that users who are more aware that they may become diabetic will take significant actions to prevent it.
In addition to Apple and Samsung, other companies are trying to solve the problem in their own way, even though they all have the same regulatory hurdles to overcome. As with the Apple Watch’s ECG function, any proposed blood glucose function will have to be passed on to the U.S. Food and Drug Administration and international counterparts before it can be used in each country.